跳至主要内容
临床试验/NCT02376621
NCT02376621已完成1 期

Nutrition Products - An Open-Label, Randomised, Single-Dose Study to Evaluate the Bioavailability of Omega-3 Based Dietary Supplements Under Fasting Conditions in Healthy Male and Female Subjects

Pronova BioPharma2 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2014年10月1日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
24
试验地点
2
主要终点
Area under curve of omega-3 based dietary supplements under fasted conditions.

研究概览

简要总结

The study will evaluate the bioavailability of omega-3 based dietary supplements under fasted conditions in healthy adult subjects. Each subject will participate in 5 treatment periods. The order of treatments will be in accordance with the randomisation schedule.There will be a minimum of 4 treatment-free days between each treatment period. On each dosing occasion, subjects will be fasted for at least 10 hours overnight, prior to the morning of dosing. Twenty-four subjects will be enrolled to complete dosing of 20 subjects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
盲法
None

入排标准

年龄范围
40 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • males or females
  • any ethnic origin
  • age 40 - 65 years
  • BMI 18.5 - 30.0 kg/m2
  • generally in good health
  • signed informed consent

排除标准

  • males or females not willing to use appropriate contraception
  • prescribed systemic or topical medication taken within 14 days
  • taken supplements containing omega-3 faty acids or fish oil last 14 days or any non-prescribed systemic or topical medication including herbal remedies and vitamin/mineral supplements within 7 days
  • taken any medication including St. John's Worth known to alter drug absorption within 30 days
  • subjects participating in a clinical study past 3 months
  • recent blood donation
  • significant history of drug allergy or any allergic disease
  • allergy or hypersensitivity to omega-3 fatty acids, fish, soya, oleic acid, sesame oil or other constituents of pharmaceutical preparation.
  • high consumption of tobacco
  • high consumption of alcohol
  • other significant medical history or physical findings (including HIV,hepatitis)
  • vegetarians
  • not willing to follow dietary restrictions
  • frequent migraine attacks
  • previously taken part in or withdrawn from study or according to investigator should not participate.

结局指标

主要结局

Area under curve of omega-3 based dietary supplements under fasted conditions.

时间窗: Pharmacokinetics up to 36 hours postdose

Peak plasma concentration of omega-3 based dietary supplements under fasted conditions.

时间窗: Pharmacokinetics up to 36 hours postdose

次要结局

未报告次要终点

研究者

发起方
Pronova BioPharma
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验